The Medical Letter on Drugs and Therapeutics
FROM
ISSUE839
ISSUE839
March 8, 1991
A Subdermal Progestin Implant For Long-Term Contraception
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
A Subdermal Progestin Implant For Long-Term Contraception
March 8, 1991 (Issue: 839)
The Norplant System (Wyeth-Ayerst) for subdermal delivery of the synthetic progestin levonorgestrel was recently approved by the US Food and Drug Administration for use as a long-term contraceptive.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.